Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection
- 15 November 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (10) , 3449-3456
- https://doi.org/10.1182/blood-2005-02-0536
Abstract
Human parvovirus B19 (B19) infects human erythroid cells expressing P antigen. However, some cell lines that were positive for P antigen failed to bind B19, whereas some cell lines had an ability to bind B19 despite undetectable expression of P antigen. We here demonstrate that B19 specifically binds with Ku80 autoantigen on the cell surface. Furthermore, transfection of HeLa cells with the gene of Ku80 enabled the binding of B19 and allowed its entry into cells. Moreover, reduction of cell-surface expression of Ku80 in KU812Ep6 cells, which was a high-sensitive cell line for B19 infection, by short interfering RNA for Ku80 resulted in the marked inhibition of B19 binding in KU812Ep6 cells. Although Ku80 originally has been described as a nuclear protein, human bone marrow erythroid cells with glycophorin A or CD36, B cells with CD20, or T cells with CD3 were all positive for cell-surface expression of Ku80. B19 infection of KU812Ep6 cells and bone marrow cells was inhibited in the presence of anti-Ku80 antibody. Our data suggest that Ku80 functions as a novel coreceptor for B19 infection, and this finding may provide an explanation for the pathologic immunity associated with B19 infection.Keywords
This publication has 42 references indexed in Scilit:
- Parvovirus B19 does not bind to membrane-associated globoside in vitroVirology, 2005
- α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entryBlood, 2003
- Recombinant Human Parvovirus B19 Vectors: Erythrocyte P Antigen Is Necessary but Not Sufficient for Successful Transduction of Human Hematopoietic CellsJournal of Virology, 2001
- Parvovirus B19 causing leucopenia and neutropenia in a healthy adultJournal of Infection, 2000
- Rheumatoid arthritis after human parvovirus B19 infectionAnnals of the Rheumatic Diseases, 1999
- PARVOVIRUS B19 IN HUMAN DISEASEAnnual Review of Medicine, 1997
- Systemic Monocyte and T-Cell Activation in a Patient With Human Parvovirus B19 InfectionMayo Clinic Proceedings, 1995
- Erythrocyte P Antigen: Cellular Receptor for B19 ParvovirusScience, 1993
- Experimental Parvoviral Infection in HumansThe Journal of Infectious Diseases, 1985
- HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?The Lancet, 1983